The FDA has authorized the first artificial intelligence-powered medical device to help doctors detect the most common forms of skin cancer in patients.
The non-invasive, handheld device uses AI-powered spectroscopy tech to assess cellular and below-the-skin's-surface characteristics of lesions on a patient's skin.
[
add
]
[
|
|
...
]